BIOA

BioAge Labs, Inc. Common Stock
Data: 2026-02-02
$20.1
Price
7.27%
Change
$24
52W High
$2.88
52W Low

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Quick Stats
Feb 02, 2026

52.5

AI Score

HOLD

0.95

Volume Ratio

Mar 19, 2026

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

BIOA Stock Summary

Last updated Feb 02, 2026

BIOA is currently trading at $20.1, positioned above its 200-day moving average of $7.3, indicating a long-term uptrend. The stock has a 52-week range of $2.88 to $24.

Technical Analysis: The 50-day moving average stands at $14.25, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 62.091, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.127, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BIOA at 52.5/100 with a HOLD recommendation.

BIOA (BioAge Labs, Inc. Common Stock) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 62.091
CMF (20) 0.127
ROC (10) -0.298
ADX (14) 43.626
Indicator Value
MACD (12,26,9) 1.599
AROONOSC (14) 21.429
WILLAMS %R (14) -51.316
MFI (14) 50.518
BIOA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BIOA Price vs Max Options Open Interest
BIOA Max Change In Options Open Interest

BIOA Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIOA Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIOA Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIOA Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

BioAge Labs, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.

BIOA Moving Averages Analysis

BioAge Labs, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026

BioAge Labs, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026

BIOA (BioAge Labs, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 19.5
20 18.45
30 16.77
50 14.25
100 10.24
200 7.3

BIOA Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) 1.3953
Market Cap ($) 792.9 million
Earnings/Share ($) 13.61
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.2019
EPS Estimate Next Year ($) -2.8144
WallStreet Target Price ($) 12
Most Recent Quarter